Axelar AB Information

Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for the treatment of cancer and other diseases.

Website	http://www.axelar.se
Revenue	$1 million
Employees	1 (1 on RocketReach)
Founded	2003
Address	2 Fogdevreten, Solna SE-171 65, SE
Phone	+46 8 524 865 99
Technologies	Slack , Instagram , Freshdesk +1 more (view full list)
Industry	Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering
Web Rank	18 Million
Keywords	Biomedical Research, Biotechnology, Molecular Biology, Cancer Treatment, Drug Development, Life Sciences, Pharmaceutical Research, Oncology, Biotech Research, Disease Treatment, Medical Research, Pharmaceutical, Biologics, Therapeutics, Clinical Trials, New Drug Discovery, Drug Discovery
Competitors	Circle, Chainalysis, Alchemy, Blockchain.com, Consensys Diligence, CoinDesk, BlockFi, Bitfinex, RECDeFi, Infura +43 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies